Guangdong Jiaying Pharmaceutical Co., Ltd

SZSE:002198.SZ

6.3 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Revenue 533.233659.196574.713544.729500.504536.984468.081449.951475.805565.82226.745104.47385.91375.24762.33266.34564.58162.6754.34837.46
Cost of Revenue 185.513228.528141.905146.535106.38144.004125.034104.733126.708221.25296.7952.10445.08234.20425.82826.86423.86324.08824.63721.981
Gross Profit 347.72430.667432.809398.194394.124392.979343.047345.217349.097344.568129.95452.36940.83141.04336.50539.48240.71738.58329.71115.479
Gross Profit Ratio 0.6520.6530.7530.7310.7870.7320.7330.7670.7340.6090.5730.5010.4750.5450.5860.5950.630.6160.5470.413
Reseach & Development Expenses 10.09815.3414.4019.37814.35312.40710.10811.20212.2315.2452.04500.0510000000
General & Administrative Expenses 13.95712.45314.19813.00517.12412.58711.91113.13613.04612.12110.2356.5486.34816.76415.18112.6737.3926.1226.416.455
Selling & Marketing Expenses 244.765307.439328.341299.909306.061275.67235.285202.538210.349198.76966.68437.64217.52619.09512.77213.9127.1317.9786.455.507
SG&A 258.722319.893342.539312.914323.185288.257247.196215.674223.395210.8976.91944.19123.87435.85927.95426.58514.52314.10112.8611.962
Other Expenses -1.14240.73346.28542.86547.1110.4931.079-0.0313.93511.4414.0072.0081.2193.5132.752.5836.3711.6340.5030.521
Operating Expenses 310.41375.965403.225365.157384.649346.086304.572274.48274.228263.067101.16562.02840.68436.78428.5927.35515.27814.86813.48712.265
Operating Income 40.51553.88433.64324.0538.94341.839-206.90966.68674.44876.181176.3445.0419.62722.67814.02512.74523.70423.10815.5032.844
Operating Income Ratio 0.0760.0820.0590.0440.0180.078-0.4420.1480.1560.1350.7780.0480.2280.3010.2250.1920.3670.3690.2850.076
Total Other Income Expenses Net 2.063-2.787-27.82-1.031-123.124-4.561-244.305-4.1123.3635.806150.53216.70720.69921.9328.8613.9373.3310.894-0.781-0.37
Income Before Tax 39.37451.0975.82323.022-114.18142.331-205.8366.62678.23387.307179.3227.04820.84626.19116.77516.06328.77124.60815.4432.844
Income Before Tax Ratio 0.0740.0780.010.042-0.2280.079-0.440.1480.1640.1540.7910.0670.2430.3480.2690.2420.4460.3930.2840.076
Income Tax Expense 5.0537.1634.3463.1848.0046.4538.93211.45411.87813.65339.832-0.520.6070.9441.6962.3424.3522.4950.0250.075
Net Income 34.3243.9351.47719.838-122.18435.879-214.76255.17266.35573.654139.4917.56820.23925.24715.07913.72124.41922.11315.4192.769
Net Income Ratio 0.0640.0670.0030.036-0.2440.067-0.4590.1230.1390.130.6150.0720.2360.3360.2420.2070.3780.3530.2840.074
EPS 0.0680.0870.0030.039-0.240.071-0.420.110.130.150.330.0190.0490.0620.0360.0340.080.0720.050.01
EPS Diluted 0.0680.0870.0030.039-0.240.071-0.420.110.130.150.330.0190.0490.0620.0360.0340.080.0720.050.01
EBITDA 63.0580.51362.0457.57436.1276.3267.06798.676102.315116.609201.53923.95837.79639.21823.88823.01536.06929.70820.3475.21
EBITDA Ratio 0.1180.1220.1080.1060.0720.1420.1430.2190.2150.2060.8890.2290.440.5210.3830.3470.5590.4740.3740.139